(BC8) Bechtle - Ratings and Ratios
Hardware, Software, Consulting, Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.80% |
| Yield on Cost 5y | 1.32% |
| Yield CAGR 5y | -15.14% |
| Payout Consistency | 98.7% |
| Payout Ratio | 40.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 29.4% |
| Value at Risk 5%th | 42.7% |
| Relative Tail Risk | -11.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.99 |
| Alpha | 37.78 |
| CAGR/Max DD | 0.15 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.474 |
| Beta | 0.230 |
| Beta Downside | 0.428 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.19% |
| Mean DD | 15.61% |
| Median DD | 14.72% |
Description: BC8 Bechtle January 08, 2026
Bechtle AG (XETRA: BC8) is a European-focused IT services provider operating through two main segments: IT System House & Managed Services, which delivers strategy consulting, system integration, hardware/software procurement, and training; and IT E-Commerce, which sells hardware, software, and accessories via an online shop. The firm also offers data-center, networking, security, e-procurement, and a broad portfolio of enterprise software applications-including BI, ERP, PLM, CAD/CAM, and AI solutions-to industrial, trade, financial, and public-sector clients.
Key recent metrics show FY 2023 revenue of €6.2 billion, with an operating margin of roughly 5 % and an 8 % year-over-year increase in Managed Services revenue, reflecting strong demand for cloud migration and outsourced IT operations. The segment’s growth is underpinned by a broader European trend of rising cybersecurity spend (projected CAGR > 10 % through 2027) and EU digital-transformation initiatives that are accelerating IT outsourcing. Labor shortages in the German IT talent market further reinforce the appeal of Bechtle’s managed-services model.
For a deeper quantitative view, you might explore Bechtle’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (215.2m TTM) > 0 and > 6% of Revenue (6% = 381.2m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -4.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 15.40% (prev 18.19%; Δ -2.79pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 416.7m > Net Income 215.2m (YES >=105%, WARN >=100%) |
| Net Debt (111.9m) to EBITDA (486.8m) ratio: 0.23 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.68 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (126.0m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 18.07% (prev 17.71%; Δ 0.36pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 160.3% (prev 166.9%; Δ -6.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.94 (EBITDA TTM 486.8m / Interest Expense TTM 27.6m) >= 6 (WARN >= 3) |
Altman Z'' 4.44
| (A) 0.24 = (Total Current Assets 2.42b - Total Current Liabilities 1.44b) / Total Assets 4.10b |
| (B) 0.42 = Retained Earnings (Balance) 1.74b / Total Assets 4.10b |
| (C) 0.08 = EBIT TTM 330.0m / Avg Total Assets 3.96b |
| (D) 0.89 = Book Value of Equity 1.89b / Total Liabilities 2.13b |
| Total Rating: 4.44 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 67.89
| 1. Piotroski 6.0pt |
| 2. FCF Yield 5.36% |
| 3. FCF Margin 4.71% |
| 4. Debt/Equity 0.28 |
| 5. Debt/Ebitda 0.23 |
| 6. ROIC - WACC (= 5.05)% |
| 7. RoE 11.14% |
| 8. Rev. Trend 46.54% |
| 9. EPS Trend -52.50% |
What is the price of BC8 shares?
Over the past week, the price has changed by +0.14%, over one month by +0.78%, over three months by +24.45% and over the past year by +46.04%.
Is BC8 a buy, sell or hold?
What are the forecasts/targets for the BC8 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.1 | 0.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 49.8 | 13.5% |
BC8 Fundamental Data Overview January 11, 2026
P/E Trailing = 25.3684
P/S = 0.8604
P/B = 2.8209
Revenue TTM = 6.35b EUR
EBIT TTM = 330.0m EUR
EBITDA TTM = 486.8m EUR
Long Term Debt = 402.8m EUR (from longTermDebt, last quarter)
Short Term Debt = 148.1m EUR (from shortTermDebt, last quarter)
Debt = 550.9m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 111.9m EUR (from netDebt column, last quarter)
Enterprise Value = 5.58b EUR (5.47b + Debt 550.9m - CCE 439.0m)
Interest Coverage Ratio = 11.94 (Ebit TTM 330.0m / Interest Expense TTM 27.6m)
EV/FCF = 18.66x (Enterprise Value 5.58b / FCF TTM 299.0m)
FCF Yield = 5.36% (FCF TTM 299.0m / Enterprise Value 5.58b)
FCF Margin = 4.71% (FCF TTM 299.0m / Revenue TTM 6.35b)
Net Margin = 3.39% (Net Income TTM 215.2m / Revenue TTM 6.35b)
Gross Margin = 18.07% ((Revenue TTM 6.35b - Cost of Revenue TTM 5.20b) / Revenue TTM)
Gross Margin QoQ = 18.39% (prev 18.41%)
Tobins Q-Ratio = 1.36 (Enterprise Value 5.58b / Total Assets 4.10b)
Interest Expense / Debt = 1.22% (Interest Expense 6.73m / Debt 550.9m)
Taxrate = 28.99% (23.3m / 80.5m)
NOPAT = 234.4m (EBIT 330.0m * (1 - 28.99%))
Current Ratio = 1.68 (Total Current Assets 2.42b / Total Current Liabilities 1.44b)
Debt / Equity = 0.28 (Debt 550.9m / totalStockholderEquity, last quarter 1.96b)
Debt / EBITDA = 0.23 (Net Debt 111.9m / EBITDA 486.8m)
Debt / FCF = 0.37 (Net Debt 111.9m / FCF TTM 299.0m)
Total Stockholder Equity = 1.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.43% (Net Income 215.2m / Total Assets 4.10b)
RoE = 11.14% (Net Income TTM 215.2m / Total Stockholder Equity 1.93b)
RoCE = 14.13% (EBIT 330.0m / Capital Employed (Equity 1.93b + L.T.Debt 402.8m))
RoIC = 11.27% (NOPAT 234.4m / Invested Capital 2.08b)
WACC = 6.22% (E(5.47b)/V(6.02b) * Re(6.76%) + D(550.9m)/V(6.02b) * Rd(1.22%) * (1-Tc(0.29)))
Discount Rate = 6.76% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 85.02% ; FCFF base≈364.4m ; Y1≈364.6m ; Y5≈386.5m
Fair Price DCF = 81.81 (EV 10.42b - Net Debt 111.9m = Equity 10.31b / Shares 126.0m; r=6.22% [WACC]; 5y FCF grow -0.49% → 2.90% )
EPS Correlation: -52.50 | EPS CAGR: -45.79% | SUE: -4.0 | # QB: 0
Revenue Correlation: 46.54 | Revenue CAGR: 17.54% | SUE: 0.32 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.45 | Chg30d=+0.012 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=2.10 | Chg30d=+0.005 | Revisions Net=-1 | Growth EPS=+16.2% | Growth Revenue=+6.6%